CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Total Revenues		$ 46,385	$ 42,518	$ 26,145
Cost of products sold	[1]	9,940	11,773	8,078
Marketing, selling and administrative		7,690	7,661	4,871
Research and development		11,354	11,143	6,148
IPRD charge - MyoKardia acquisition		0	11,438	0
Amortization of acquired intangible assets		10,023	9,688	1,135
Other (income)/expense, net		(720)	(2,314)	938
Total Expenses		38,287	49,389	21,170
Earnings/(Loss) Before Income Taxes		8,098	(6,871)	4,975
Provision for Income Taxes		1,084	2,124	1,515
Net Earnings/(Loss)		7,014	(8,995)	3,460
Noncontrolling Interest		20	20	21
Net Earnings(Loss) Attributable to BMS		$ 6,994	$ (9,015)	$ 3,439
Earnings per common share attributable to BMS, basic (in usd per share)		$ 3.15	$ (3.99)	$ 2.02
Earnings per common share attributable to BMS, diluted (in usd per share)		$ 3.12	$ (3.99)	$ 2.01
Net product sales
Total Revenues		$ 45,055	$ 41,321	$ 25,174
Alliance and other revenues
Total Revenues		$ 1,330	$ 1,197	$ 971

[1] Excludes amortization of acquired intangible assets.